Cholinergic Muscarinic Antagonist [EPC]

Cholinergic Muscarinic Antagonist [EPC] was reported 39246 times

Drugs of the Cholinergic Muscarinic Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL FLATULENCE 68 0.2244
1 ANTICHOLINERGIC SYNDROME 127 0.0797
2 PRODUCT CLOSURE REMOVAL DIFFICULT 71 0.0696
3 CREATININE RENAL CLEARANCE INCREASED 39 0.0521
4 MULTIPLE DRUG THERAPY 37 0.0491
5 FEMALE GENITAL TRACT FISTULA 71 0.0415
6 HYPERTONIC BLADDER 104 0.0360
7 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 38 0.0358
8 APPLICATION SITE ERYTHEMA 932 0.0355
9 BRASH SYNDROME 47 0.0335
10 BLADDER SPASM 61 0.0326
11 RADICULOPATHY 81 0.0307
12 APPLICATION SITE PAPULES 30 0.0283
13 APPLICATION SITE PRURITUS 619 0.0273
14 SEDATION COMPLICATION 69 0.0270
15 APPLICATION SITE RASH 351 0.0255
16 HYPERTHERMIA MALIGNANT 37 0.0248
17 PROCTITIS 69 0.0246
18 NEPHROGENIC ANAEMIA 114 0.0246
19 APPLICATION SITE WARMTH 31 0.0243
20 APPLICATION SITE DISCOMFORT 43 0.0239
21 PRODUCT ADHESION ISSUE 844 0.0236
22 HYPERPARATHYROIDISM SECONDARY 54 0.0215
23 NEUROGENIC BLADDER 43 0.0204
24 VASOPLEGIA SYNDROME 33 0.0201
25 APPLICATION SITE BURN 99 0.0201
26 APPLICATION SITE DISCOLOURATION 81 0.0199
27 STOMA SITE PAIN 29 0.0197
28 APPLICATION SITE INFLAMMATION 27 0.0195
29 DRUG ADMINISTERED AT INAPPROPRIATE SITE 194 0.0184
30 CHRONIC SINUSITIS 68 0.0181
31 STRESS CARDIOMYOPATHY 103 0.0177
32 SINUS ARREST 27 0.0172
33 DRUG EFFECT DELAYED 76 0.0167
34 APPLICATION SITE IRRITATION 206 0.0165
35 CREATININE RENAL CLEARANCE DECREASED 66 0.0165
36 CULTURE URINE POSITIVE 23 0.0164
37 PUPIL FIXED 26 0.0150
38 CHANGE OF BOWEL HABIT 30 0.0146
39 REBOUND ACID HYPERSECRETION 44 0.0145
40 URINE ANALYSIS ABNORMAL 43 0.0144
41 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 27 0.0144
42 BLADDER PAIN 44 0.0138
43 BLADDER DISORDER 133 0.0134
44 WHITE BLOOD CELLS URINE POSITIVE 25 0.0133
45 PULSELESS ELECTRICAL ACTIVITY 55 0.0131
46 ESSENTIAL HYPERTENSION 24 0.0131
47 URINARY INCONTINENCE 376 0.0127
48 HYPERTHERMIA 94 0.0123
49 MACULAR DEGENERATION 143 0.0120
50 SALIVARY HYPERSECRETION 119 0.0119
51 DRUG EFFECT DECREASED 640 0.0119
52 MICTURITION URGENCY 135 0.0118
53 ANTIPSYCHOTIC DRUG LEVEL INCREASED 33 0.0117
54 APPLICATION SITE PAIN 258 0.0117
55 APPLICATION SITE URTICARIA 26 0.0116
56 PRODUCT PACKAGING ISSUE 110 0.0116
57 MACULOPATHY 41 0.0115
58 LARYNGOSPASM 31 0.0115
59 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 25 0.0114
60 APLASTIC ANAEMIA 59 0.0113
61 RENAL FUNCTION TEST ABNORMAL 52 0.0112
62 CORNEAL OEDEMA 25 0.0111
63 URINE ODOUR ABNORMAL 64 0.0109
64 ATRIOVENTRICULAR BLOCK FIRST DEGREE 47 0.0108
65 URINARY TRACT INFECTION BACTERIAL 27 0.0107
66 INCONTINENCE 112 0.0106
67 EOSINOPHIL COUNT DECREASED 25 0.0105
68 ANAESTHETIC COMPLICATION 28 0.0104
69 COMA SCALE ABNORMAL 30 0.0103
70 NOCTURIA 121 0.0100
71 PULSE ABSENT 46 0.0097
72 SINUS BRADYCARDIA 93 0.0096
73 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 25 0.0095
74 URINE ABNORMALITY 43 0.0094
75 ANGLE CLOSURE GLAUCOMA 24 0.0094
76 LEFT VENTRICULAR HYPERTROPHY 40 0.0093
77 BRADYCARDIA 486 0.0092
78 DRY MOUTH 740 0.0091
79 POLLAKIURIA 377 0.0090
80 BLOOD SODIUM INCREASED 24 0.0089
81 URINARY RETENTION 291 0.0087
82 END STAGE RENAL DISEASE 159 0.0087
83 THERAPEUTIC AGENT TOXICITY 29 0.0087
84 BLOOD CREATININE DECREASED 27 0.0086
85 ORAL CANDIDIASIS 113 0.0086
86 VENTRICULAR FIBRILLATION 95 0.0085
87 WALKING AID USER 56 0.0085
88 APNOEA 65 0.0083
89 MUSCLE SPASTICITY 102 0.0083
90 APPLICATION SITE SWELLING 41 0.0082
91 CHRONIC KIDNEY DISEASE 623 0.0082
92 BLOOD CALCIUM DECREASED 92 0.0082
93 FAECAL INCONTINENCE 39 0.0081
94 WHEELCHAIR USER 36 0.0081
95 PERONEAL NERVE PALSY 46 0.0081
96 BUNDLE BRANCH BLOCK RIGHT 37 0.0081
97 CREPITATIONS 24 0.0081
98 ORTHOSTATIC HYPOTENSION 140 0.0080
99 URINARY TRACT DISORDER 36 0.0080
100 ATRIOVENTRICULAR BLOCK SECOND DEGREE 24 0.0079
101 DECUBITUS ULCER 64 0.0078
102 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 26 0.0078
103 FAECALOMA 43 0.0078
104 CEREBRAL ATROPHY 31 0.0078
105 CARDIOGENIC SHOCK 111 0.0077
106 APPLICATION SITE VESICLES 50 0.0077
107 HYPOVOLAEMIA 45 0.0077
108 CATATONIA 40 0.0076
109 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 39 0.0076
110 ESCHERICHIA URINARY TRACT INFECTION 32 0.0075
111 VAGINAL DISCHARGE 76 0.0075
112 ATRIOVENTRICULAR BLOCK COMPLETE 49 0.0073
113 APPLICATION SITE EXFOLIATION 30 0.0073
114 PARAESTHESIA ORAL 104 0.0072
115 SKIN ABRASION 34 0.0072
116 ENURESIS 29 0.0072
117 PLANTAR FASCIITIS 24 0.0071
118 VENTRICULAR EXTRASYSTOLES 74 0.0071
119 VENTRICULAR TACHYCARDIA 117 0.0071
120 BLOOD PRESSURE SYSTOLIC DECREASED 32 0.0070
121 HAEMODYNAMIC INSTABILITY 53 0.0069
122 RENAL TUBULAR NECROSIS 68 0.0069
123 URINARY TRACT INFECTION 1178 0.0069
124 MYDRIASIS 88 0.0069
125 BUNDLE BRANCH BLOCK LEFT 29 0.0068
126 MUSCLE CONTRACTIONS INVOLUNTARY 24 0.0068
127 UROSEPSIS 62 0.0067
128 CYSTITIS 212 0.0067
129 DYSARTHRIA 249 0.0066
130 MONOCYTE COUNT INCREASED 24 0.0066
131 TENDON DISORDER 43 0.0066
132 MENTAL STATUS CHANGES 183 0.0066
133 BALANCE DISORDER 566 0.0065
134 THERAPY CESSATION 336 0.0065
135 MITRAL VALVE INCOMPETENCE 74 0.0065
136 ECONOMIC PROBLEM 99 0.0065
137 ENDOPHTHALMITIS 39 0.0065
138 ARTERIOSPASM CORONARY 26 0.0065
139 ACUTE PULMONARY OEDEMA 36 0.0064
140 SEDATION 167 0.0064
141 RESPIRATORY ACIDOSIS 25 0.0064
142 POLYDIPSIA 25 0.0063
143 DERMATITIS CONTACT 72 0.0063
144 DELIRIUM 217 0.0062
145 PRE-EXISTING CONDITION IMPROVED 39 0.0062
146 FREEZING PHENOMENON 23 0.0062
147 HALLUCINATION, VISUAL 131 0.0062
148 MULTIPLE INJURIES 39 0.0062
149 PROTEIN TOTAL DECREASED 23 0.0061
150 MEDICATION RESIDUE PRESENT 29 0.0061
151 TRICUSPID VALVE INCOMPETENCE 48 0.0060
152 SPINAL OSTEOARTHRITIS 53 0.0060
153 DYSURIA 222 0.0060
154 BENIGN PROSTATIC HYPERPLASIA 31 0.0060
155 MULTIPLE SCLEROSIS RELAPSE 411 0.0060
156 ACUTE RESPIRATORY FAILURE 115 0.0060
157 UNRESPONSIVE TO STIMULI 153 0.0059
158 ATELECTASIS 57 0.0059
159 RENAL INJURY 175 0.0059
160 MULTIPLE SCLEROSIS 280 0.0058
161 SINUS TACHYCARDIA 83 0.0058
162 LEFT VENTRICULAR DYSFUNCTION 39 0.0058
163 INTESTINAL ISCHAEMIA 32 0.0058
164 TROPONIN INCREASED 44 0.0058
165 VITAMIN D DEFICIENCY 56 0.0057
166 NYSTAGMUS 30 0.0056
167 OLIGURIA 35 0.0056
168 LACERATION 53 0.0056
169 DIVERTICULUM 40 0.0056
170 ANKLE FRACTURE 87 0.0056
171 DERMATITIS ACNEIFORM 34 0.0056
172 ATRIOVENTRICULAR BLOCK 43 0.0056
173 CARDIOMEGALY 68 0.0055
174 BODY HEIGHT DECREASED 59 0.0055
175 EXOSTOSIS 50 0.0055
176 MOUTH ULCERATION 114 0.0054
177 FALL 1788 0.0054
178 MYOCARDIAL ISCHAEMIA 61 0.0054
179 ATAXIA 63 0.0053
180 SLEEP APNOEA SYNDROME 101 0.0053
181 MUSCLE RIGIDITY 63 0.0053
182 INCOHERENT 34 0.0052
183 MYOCARDITIS 60 0.0052
184 RESPIRATORY DEPRESSION 64 0.0052
185 HYDRONEPHROSIS 39 0.0052
186 MOBILITY DECREASED 370 0.0051
187 INCORRECT DRUG ADMINISTRATION DURATION 144 0.0051
188 APPLICATION SITE REACTION 36 0.0051
189 TIBIA FRACTURE 24 0.0051
190 KIDNEY INFECTION 100 0.0051
191 CARDIAC ARREST 417 0.0050
192 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 358 0.0050
193 HEPATIC ENZYME ABNORMAL 25 0.0050
194 ISCHAEMIA 23 0.0050
195 ORAL PAIN 112 0.0050
196 BLOOD URINE PRESENT 94 0.0049
197 FLANK PAIN 46 0.0049
198 ANAL INCONTINENCE 44 0.0049
199 PERIPHERAL VASCULAR DISORDER 25 0.0048
200 SKIN IRRITATION 222 0.0048
201 IMPAIRED GASTRIC EMPTYING 66 0.0048
202 FAILURE TO THRIVE 25 0.0048
203 CLOSTRIDIUM DIFFICILE COLITIS 51 0.0048
204 CARDIOMYOPATHY 71 0.0048
205 POST PROCEDURAL COMPLICATION 92 0.0048
206 CONSTIPATION 1039 0.0048
207 ELECTROCARDIOGRAM ABNORMAL 37 0.0047
208 ACIDOSIS 36 0.0047
209 DRUG TOXICITY 64 0.0047
210 NEPHROLITHIASIS 215 0.0047
211 RENAL FAILURE 621 0.0047
212 GASTROINTESTINAL MOTILITY DISORDER 25 0.0047
213 COGNITIVE DISORDER 218 0.0047
214 RENAL CYST 37 0.0047
215 TEMPERATURE INTOLERANCE 48 0.0046
216 DEMENTIA 130 0.0046
217 TRISMUS 24 0.0046
218 INTERVERTEBRAL DISC DEGENERATION 43 0.0046
219 NASAL DRYNESS 29 0.0046
220 OSTEOPENIA 70 0.0046
221 DEPRESSED LEVEL OF CONSCIOUSNESS 181 0.0046
222 RETINAL DETACHMENT 42 0.0046
223 HOSPICE CARE 45 0.0046
224 ARTERIOSCLEROSIS CORONARY ARTERY 30 0.0045
225 RESPIRATORY ARREST 124 0.0045
226 SUPRAVENTRICULAR TACHYCARDIA 43 0.0045
227 NEURALGIA 109 0.0045
228 ASPIRATION 49 0.0045
229 TORSADE DE POINTES 35 0.0045
230 PRODUCT RESIDUE PRESENT 24 0.0044
231 LIGAMENT SPRAIN 44 0.0044
232 HAEMATOCRIT DECREASED 88 0.0044
233 BEHAVIOUR DISORDER 24 0.0044
234 MUSCULAR WEAKNESS 504 0.0044
235 NEUROPATHY PERIPHERAL 419 0.0044
236 BRADYKINESIA 26 0.0044
237 ENCEPHALOPATHY 108 0.0044
238 GRANULOCYTOPENIA 25 0.0044
239 OSTEOARTHRITIS 186 0.0044
240 CENTRAL NERVOUS SYSTEM LESION 60 0.0044
241 PNEUMONIA ASPIRATION 109 0.0044
242 GAIT DISTURBANCE 833 0.0043
243 LOWER GASTROINTESTINAL HAEMORRHAGE 32 0.0043
244 BIPOLAR DISORDER 47 0.0043
245 MOTOR DYSFUNCTION 44 0.0043
246 PROCEDURAL COMPLICATION 33 0.0043
247 LYMPHOCYTE COUNT DECREASED 76 0.0043
248 HYPOTENSION 859 0.0043
249 UPPER GASTROINTESTINAL HAEMORRHAGE 72 0.0043
250 SCHIZOPHRENIA 52 0.0043
251 WRIST FRACTURE 51 0.0043
252 POOR VENOUS ACCESS 44 0.0042
253 ACUTE KIDNEY INJURY 650 0.0042
254 HAND FRACTURE 30 0.0042
255 INTERVERTEBRAL DISC PROTRUSION 92 0.0042
256 RASH ERYTHEMATOUS 201 0.0042
257 HEART RATE DECREASED 147 0.0042
258 ILEUS 52 0.0042
259 THERAPY INTERRUPTED 298 0.0042
260 GENERALISED TONIC-CLONIC SEIZURE 69 0.0042
261 FOOT FRACTURE 79 0.0042
262 INTRAOCULAR PRESSURE INCREASED 53 0.0041
263 ATRIAL FLUTTER 33 0.0041
264 ROTATOR CUFF SYNDROME 53 0.0041
265 SKIN WARM 24 0.0041
266 OXYGEN SATURATION DECREASED 231 0.0041
267 ANHEDONIA 108 0.0041
268 PSYCHOLOGICAL TRAUMA 35 0.0041
269 TACHYCARDIA 360 0.0040
270 HYPERKALAEMIA 142 0.0040
271 HYSTERECTOMY 35 0.0040
272 CONFUSIONAL STATE 653 0.0040
273 DRY THROAT 41 0.0040
274 LARGE INTESTINE PERFORATION 28 0.0040
275 RENAL FAILURE CHRONIC 31 0.0040
276 HAEMATURIA 138 0.0040
277 OESOPHAGITIS 44 0.0040
278 RECTAL HAEMORRHAGE 173 0.0040
279 CARDIAC PACEMAKER INSERTION 24 0.0040
280 HEMIPARESIS 68 0.0040
281 TONGUE DISORDER 29 0.0040
282 CONCUSSION 31 0.0040
283 NEUTROPHIL COUNT INCREASED 41 0.0040
284 CARDIO-RESPIRATORY ARREST 167 0.0040
285 DELUSION 62 0.0040
286 OBSESSIVE-COMPULSIVE DISORDER 32 0.0040
287 PRODUCT QUALITY ISSUE 541 0.0040
288 DYSSTASIA 116 0.0040
289 HYPOXIA 139 0.0039
290 HALLUCINATION 297 0.0039
291 ERYTHEMA 810 0.0039
292 PERIPHERAL COLDNESS 54 0.0039
293 PARALYSIS 56 0.0039
294 SPINAL OPERATION 48 0.0039
295 PSYCHOTIC DISORDER 115 0.0039
296 FOOT DEFORMITY 43 0.0039
297 SPINAL COMPRESSION FRACTURE 32 0.0039
298 EXTRASYSTOLES 27 0.0039
299 BODY TEMPERATURE DECREASED 38 0.0039
300 DRUG EFFECT INCOMPLETE 140 0.0039
301 ODYNOPHAGIA 23 0.0038
302 COLITIS 145 0.0038
303 PRODUCT ADMINISTRATION INTERRUPTED 30 0.0038
304 MULTI-ORGAN FAILURE 66 0.0038
305 CHROMATURIA 86 0.0038
306 SOMNAMBULISM 25 0.0038
307 HAEMATOCHEZIA 209 0.0038
308 POLYURIA 31 0.0038
309 FREQUENT BOWEL MOVEMENTS 102 0.0038
310 URINE OUTPUT DECREASED 33 0.0038
311 PARANOIA 65 0.0038
312 DROOLING 26 0.0038
313 HIP FRACTURE 121 0.0038
314 EXPIRED PRODUCT ADMINISTERED 125 0.0038
315 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 31 0.0038
316 FACIAL PARALYSIS 32 0.0038
317 FEBRILE NEUTROPENIA 249 0.0037
318 HYPOTHERMIA 38 0.0037
319 DRUG INTERACTION 595 0.0037
320 BLOOD PRESSURE FLUCTUATION 90 0.0037
321 SMALL INTESTINAL OBSTRUCTION 46 0.0037
322 PROCTALGIA 24 0.0037
323 HEAD INJURY 118 0.0037
324 ARTERIOSCLEROSIS 35 0.0037
325 HALLUCINATION, AUDITORY 59 0.0037
326 DISORIENTATION 147 0.0037
327 BLOOD MAGNESIUM DECREASED 32 0.0037
328 HIATUS HERNIA 48 0.0037
329 COLITIS ISCHAEMIC 25 0.0037
330 ATRIAL FIBRILLATION 360 0.0037
331 PARKINSONISM 36 0.0037
332 GLOMERULAR FILTRATION RATE DECREASED 45 0.0037
333 BLEPHAROSPASM 23 0.0036
334 HYPOKINESIA 53 0.0036
335 DYSGRAPHIA 24 0.0036
336 MUCOSAL INFLAMMATION 95 0.0036
337 DYSKINESIA 147 0.0036
338 HYPOTONIA 36 0.0036
339 MYASTHENIA GRAVIS 29 0.0036
340 RENAL FAILURE ACUTE 152 0.0036
341 INTESTINAL OBSTRUCTION 135 0.0036
342 GRAND MAL CONVULSION 33 0.0036
343 UPPER LIMB FRACTURE 71 0.0036
344 PULMONARY HYPERTENSION 74 0.0035
345 BLOOD PRESSURE SYSTOLIC INCREASED 69 0.0035
346 BURNING SENSATION 248 0.0035
347 TOOTH ABSCESS 36 0.0035
348 DRUG INEFFECTIVE 4640 0.0035
349 HYPOPHAGIA 90 0.0035
350 RESTLESS LEGS SYNDROME 64 0.0035
351 DYSPHAGIA 334 0.0035
352 GINGIVAL PAIN 28 0.0035
353 LUNG INFILTRATION 31 0.0035
354 EYE MOVEMENT DISORDER 24 0.0035
355 CONTUSION 336 0.0035
356 HEMIPLEGIA 29 0.0035
357 PULMONARY OEDEMA 156 0.0035
358 RESPIRATION ABNORMAL 24 0.0035
359 BLINDNESS UNILATERAL 49 0.0035
360 WRONG TECHNIQUE IN DRUG USAGE PROCESS 126 0.0035
361 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 180 0.0034
362 EAR PAIN 67 0.0034
363 RESPIRATORY FAILURE 251 0.0034
364 COORDINATION ABNORMAL 48 0.0034
365 ABASIA 85 0.0034
366 MEMORY IMPAIRMENT 472 0.0034
367 GLAUCOMA 66 0.0034
368 LIMB DISCOMFORT 106 0.0034
369 INITIAL INSOMNIA 35 0.0034
370 COMA 162 0.0034
371 TACHYPNOEA 46 0.0034
372 THERMAL BURN 24 0.0034
373 STATUS EPILEPTICUS 38 0.0034
374 TUBULOINTERSTITIAL NEPHRITIS 63 0.0034
375 IRON DEFICIENCY ANAEMIA 31 0.0034
376 VITREOUS FLOATERS 33 0.0034
377 TOOTH FRACTURE 37 0.0034
378 CARDIAC MURMUR 29 0.0033
379 DEHYDRATION 447 0.0033
380 HYPERLIPIDAEMIA 40 0.0033
381 CIRCULATORY COLLAPSE 57 0.0033
382 PYELONEPHRITIS 29 0.0033
383 DENTAL CARIES 37 0.0033
384 HYPOKALAEMIA 154 0.0033
385 SPEECH DISORDER 174 0.0033
386 PROCEDURAL PAIN 92 0.0033
387 GAIT INABILITY 110 0.0033
388 NEUROLEPTIC MALIGNANT SYNDROME 39 0.0033
389 BLOOD UREA INCREASED 55 0.0033
390 OSTEOPOROSIS 135 0.0033
391 APHASIA 99 0.0033
392 SOMNOLENCE 659 0.0033
393 MUSCLE TIGHTNESS 53 0.0033
394 HYPERCALCAEMIA 40 0.0032
395 BLOOD SODIUM DECREASED 61 0.0032
396 SENSORY LOSS 26 0.0032
397 HAEMORRHOIDS 63 0.0032
398 APHONIA 45 0.0032
399 BRONCHOSPASM 46 0.0032
400 GASTROENTERITIS 47 0.0032
401 FRUSTRATION TOLERANCE DECREASED 26 0.0032
402 SHOCK 74 0.0032
403 SCAR 55 0.0032
404 AMNESIA 209 0.0032
405 HYPERSOMNIA 92 0.0032
406 MOVEMENT DISORDER 103 0.0032
407 BLOOD IRON DECREASED 38 0.0032
408 DIZZINESS POSTURAL 31 0.0032
409 RASH PRURITIC 173 0.0032
410 PULMONARY CONGESTION 42 0.0032
411 SEPSIS 353 0.0032
412 FAECES SOFT 23 0.0032
413 METABOLIC ACIDOSIS 101 0.0032
414 PULMONARY MASS 47 0.0032
415 INFUSION RELATED REACTION 209 0.0032
416 LEUKOCYTOSIS 57 0.0031
417 EYE INFLAMMATION 30 0.0031
418 SUBDURAL HAEMATOMA 45 0.0031
419 TOXICITY TO VARIOUS AGENTS 530 0.0031
420 ANAPHYLACTIC SHOCK 81 0.0031
421 DRUG LEVEL INCREASED 52 0.0031
422 SCIATICA 50 0.0031
423 LIPASE INCREASED 24 0.0031
424 GASTROOESOPHAGEAL REFLUX DISEASE 252 0.0031
425 MALNUTRITION 35 0.0031
426 BLOOD CREATINE PHOSPHOKINASE INCREASED 90 0.0031
427 BLOOD POTASSIUM DECREASED 94 0.0031
428 SKIN REACTION 44 0.0031
429 DIPLOPIA 81 0.0031
430 RED BLOOD CELL COUNT DECREASED 89 0.0031
431 MYOCLONUS 37 0.0031
432 ACCIDENT 37 0.0031
433 UVEITIS 42 0.0031
434 HYPOMAGNESAEMIA 43 0.0031
435 VISION BLURRED 424 0.0031
436 HYPOALBUMINAEMIA 24 0.0031
437 LIP DRY 28 0.0031
438 MUSCLE TWITCHING 71 0.0031
439 CELLULITIS 155 0.0031
440 ASTHENIA 1154 0.0031
441 RIB FRACTURE 63 0.0031
442 DYSPEPSIA 301 0.0031
443 ELECTROCARDIOGRAM QT PROLONGED 110 0.0031
444 HYPONATRAEMIA 172 0.0031
445 DYSPNOEA EXERTIONAL 115 0.0031
446 HYPOAESTHESIA ORAL 46 0.0030
447 MUSCULOSKELETAL DISORDER 58 0.0030
448 HICCUPS 25 0.0030
449 RHABDOMYOLYSIS 127 0.0030
450 JOINT DISLOCATION 32 0.0030
451 ARTHRITIS 238 0.0030
452 THIRST 54 0.0030
453 LOWER LIMB FRACTURE 58 0.0030
454 CARPAL TUNNEL SYNDROME 42 0.0030
455 KNEE ARTHROPLASTY 63 0.0030
456 LABORATORY TEST ABNORMAL 88 0.0030
457 AGITATION 219 0.0030
458 SINUS DISORDER 59 0.0030
459 HYPERTENSION 631 0.0030
460 DYSPHONIA 174 0.0030
461 MUSCULOSKELETAL CHEST PAIN 46 0.0030
462 PNEUMOTHORAX 47 0.0030
463 PRURITUS 1138 0.0030
464 BACK INJURY 32 0.0029
465 HIP ARTHROPLASTY 45 0.0029
466 SYNCOPE 293 0.0029
467 OSTEOMYELITIS 53 0.0029
468 ELECTROLYTE IMBALANCE 34 0.0029
469 CYANOSIS 46 0.0029
470 TOOTH DISORDER 65 0.0029
471 CATARACT 174 0.0029
472 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 30 0.0029
473 LETHARGY 168 0.0029
474 BLOOD PRESSURE DECREASED 194 0.0029
475 HAEMATEMESIS 74 0.0029
476 HYPOAESTHESIA 436 0.0029
477 HOT FLUSH 219 0.0029
478 JOINT INJURY 62 0.0029
479 FEAR 78 0.0029
480 ACUTE CORONARY SYNDROME 24 0.0029
481 COMPLETED SUICIDE 241 0.0029
482 DRY EYE 144 0.0029
483 ACUTE MYOCARDIAL INFARCTION 85 0.0029
484 COAGULOPATHY 48 0.0029
485 WEIGHT FLUCTUATION 30 0.0029
486 SENSORY DISTURBANCE 46 0.0029
487 EATING DISORDER 61 0.0029
488 SKIN LACERATION 31 0.0028
489 ROAD TRAFFIC ACCIDENT 119 0.0028
490 BACK PAIN 660 0.0028
491 HEART RATE IRREGULAR 64 0.0028
492 THERAPEUTIC RESPONSE UNEXPECTED 127 0.0028
493 LYMPHOPENIA 40 0.0028
494 BEDRIDDEN 37 0.0028
495 BRONCHITIS 208 0.0028
496 IRRITABLE BOWEL SYNDROME 60 0.0028
497 NO THERAPEUTIC RESPONSE 34 0.0028
498 SKIN DISCOLOURATION 128 0.0028
499 NEPHROPATHY 26 0.0028
500 GINGIVAL BLEEDING 38 0.0028
501 THERAPY NON-RESPONDER 125 0.0028
502 SURGERY 163 0.0028
503 EMPHYSEMA 28 0.0028
504 PRURITUS GENERALISED 60 0.0028
505 CORONARY ARTERY DISEASE 84 0.0028
506 DEPRESSION 631 0.0028
507 BLOOD TRIGLYCERIDES INCREASED 49 0.0028
508 HAIR TEXTURE ABNORMAL 37 0.0028
509 PLEURAL EFFUSION 168 0.0028
510 PHARYNGEAL SWELLING 27 0.0028
511 CLOSTRIDIUM DIFFICILE INFECTION 60 0.0027
512 FATIGUE 2139 0.0027
513 RASH MACULAR 96 0.0027
514 DIZZINESS 1367 0.0027
515 CARDIAC FAILURE CONGESTIVE 220 0.0027
516 OEDEMA PERIPHERAL 333 0.0027
517 SPINAL PAIN 32 0.0027
518 GASTROINTESTINAL HAEMORRHAGE 228 0.0027
519 EMOTIONAL DISORDER 84 0.0027
520 ABDOMINAL PAIN 632 0.0027
521 SEPTIC SHOCK 118 0.0027
522 PRODUCT DOSE OMISSION 177 0.0027
523 TREMOR 450 0.0027
524 MUSCLE SPASMS 497 0.0027
525 CORONARY ARTERY OCCLUSION 37 0.0027
526 CONDITION AGGRAVATED 820 0.0027
527 BACTERAEMIA 32 0.0027
528 VERTIGO 164 0.0027
529 BONE DISORDER 49 0.0027
530 PNEUMONIA 870 0.0027
531 SEIZURE 310 0.0027
532 MUSCLE ATROPHY 34 0.0027
533 BRAIN FOG 42 0.0027
534 APPENDICITIS 25 0.0027
535 MUSCULOSKELETAL DISCOMFORT 46 0.0027
536 WEIGHT DECREASED 746 0.0027
537 DIARRHOEA 1725 0.0027
538 PERIPHERAL SWELLING 411 0.0027
539 BLOOD PRESSURE ABNORMAL 53 0.0027
540 MENTAL DISORDER 116 0.0027
541 CHOKING 52 0.0027
542 BLISTER 149 0.0027
543 LIVER FUNCTION TEST ABNORMAL 77 0.0026
544 RESPIRATORY DISTRESS 73 0.0026
545 FUNGAL INFECTION 88 0.0026
546 IMPAIRED DRIVING ABILITY 30 0.0026
547 VISUAL IMPAIRMENT 327 0.0026
548 EJECTION FRACTION DECREASED 41 0.0026
549 OBESITY 42 0.0026
550 FLUSHING 267 0.0026
551 PULMONARY EMBOLISM 249 0.0026
552 ANAEMIA 498 0.0026
553 LOCALISED INFECTION 63 0.0026
554 UNEVALUABLE EVENT 197 0.0026
555 MENTAL IMPAIRMENT 63 0.0026
556 THYROID DISORDER 40 0.0026
557 LOSS OF CONSCIOUSNESS 332 0.0026
558 TENDERNESS 27 0.0026
559 DISCOMFORT 158 0.0026
560 GASTRITIS 68 0.0026
561 BACK DISORDER 42 0.0026
562 LIMB INJURY 70 0.0026
563 HEPATIC STEATOSIS 48 0.0026
564 TRANSFUSION 27 0.0026
565 MASS 36 0.0026
566 PARAESTHESIA 403 0.0026
567 MUSCULOSKELETAL STIFFNESS 224 0.0026
568 EYE DISORDER 84 0.0026
569 POOR QUALITY SLEEP 55 0.0026
570 DEEP VEIN THROMBOSIS 166 0.0026
571 ANAPHYLACTIC REACTION 141 0.0025
572 HAEMOGLOBIN DECREASED 262 0.0025
573 CHEST PAIN 471 0.0025
574 TOOTHACHE 46 0.0025
575 EPISTAXIS 190 0.0025
576 HYPOTHYROIDISM 81 0.0025
577 HYPOCALCAEMIA 48 0.0025
578 POISONING DELIBERATE 24 0.0025
579 BLOOD POTASSIUM INCREASED 41 0.0025
580 IMPAIRED QUALITY OF LIFE 36 0.0025
581 SARS-COV-2 TEST POSITIVE 33 0.0025
582 SWOLLEN TONGUE 78 0.0025
583 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 137 0.0025
584 BRAIN INJURY 25 0.0025
585 NERVE COMPRESSION 23 0.0025
586 TRANSIENT ISCHAEMIC ATTACK 84 0.0025
587 DISSEMINATED INTRAVASCULAR COAGULATION 35 0.0025
588 PAIN 1523 0.0025
589 BURSITIS 30 0.0025
590 HERPES ZOSTER 142 0.0025
591 PSYCHOMOTOR HYPERACTIVITY 41 0.0025
592 SCRATCH 26 0.0025
593 EYELID PTOSIS 25 0.0025
594 COVID-19 PNEUMONIA 29 0.0025
595 BLINDNESS 100 0.0025
596 CHOLECYSTECTOMY 28 0.0024
597 ALTERED STATE OF CONSCIOUSNESS 53 0.0024
598 PHOTOPHOBIA 46 0.0024
599 HYPERHIDROSIS 315 0.0024
600 SINUS CONGESTION 33 0.0024
601 SKIN ULCER 63 0.0024
602 DECREASED APPETITE 566 0.0024
603 ANXIETY 692 0.0024
604 PRODUCT PHYSICAL ISSUE 49 0.0024
605 PRODUCT USE ISSUE 456 0.0024
606 INTERNATIONAL NORMALISED RATIO INCREASED 69 0.0024
607 CEREBRAL INFARCTION 59 0.0024
608 INSOMNIA 643 0.0024
609 BLOOD PRESSURE INCREASED 369 0.0024
610 MADAROSIS 28 0.0024
611 PRODUCT USE COMPLAINT 38 0.0024
612 BODY TEMPERATURE INCREASED 49 0.0024
613 WHITE BLOOD CELL COUNT INCREASED 92 0.0024
614 CONVULSION 137 0.0024
615 PROSTATIC SPECIFIC ANTIGEN INCREASED 33 0.0024
616 ARTHROPATHY 133 0.0024
617 RESPIRATORY TRACT CONGESTION 38 0.0024
618 POISONING 30 0.0024
619 PRESYNCOPE 58 0.0024
620 WHITE BLOOD CELL COUNT DECREASED 258 0.0024
621 INFECTION 344 0.0024
622 BLOOD ALKALINE PHOSPHATASE INCREASED 59 0.0024
623 BRAIN OEDEMA 30 0.0024
624 ANGINA PECTORIS 68 0.0024
625 BASAL CELL CARCINOMA 37 0.0024
626 PAIN IN EXTREMITY 697 0.0024
627 ARRHYTHMIA 112 0.0024
628 GASTROINTESTINAL PAIN 26 0.0024
629 INJURY 166 0.0024
630 HAEMATOMA 61 0.0024
631 SLEEP DISORDER 166 0.0023
632 LOCAL SWELLING 41 0.0023
633 EUPHORIC MOOD 24 0.0023
634 RESPIRATORY DISORDER 70 0.0023
635 NERVE INJURY 26 0.0023
636 KNEE OPERATION 23 0.0023
637 CYST 29 0.0023
638 VOMITING 1089 0.0023
639 PYREXIA 801 0.0023
640 PROTEINURIA 44 0.0023
641 PRESCRIBED UNDERDOSE 46 0.0023
642 OEDEMA 125 0.0023
643 MIDDLE INSOMNIA 43 0.0023
644 PLATELET COUNT INCREASED 30 0.0023
645 RASH 1003 0.0023
646 FLUID RETENTION 117 0.0023
647 PETECHIAE 24 0.0023
648 DISEASE PROGRESSION 272 0.0023
649 PULMONARY FIBROSIS 44 0.0023
650 CHOLELITHIASIS 75 0.0023
651 PRODUCTIVE COUGH 109 0.0023
652 COLITIS ULCERATIVE 102 0.0023
653 DRUG ADMINISTRATION ERROR 70 0.0023
654 STAPHYLOCOCCAL INFECTION 75 0.0023
655 FRACTURE 43 0.0023
656 ACCIDENTAL OVERDOSE 83 0.0023
657 FEEDING DISORDER 46 0.0023
658 HYPOGLYCAEMIA 110 0.0023
659 CHOLECYSTITIS 27 0.0023
660 RENAL PAIN 24 0.0023
661 PAIN IN JAW 64 0.0023
662 HAEMOPTYSIS 63 0.0023
663 VISUAL ACUITY REDUCED 75 0.0023
664 PHARYNGITIS 28 0.0023
665 ABSCESS 36 0.0023
666 EXTRAPYRAMIDAL DISORDER 56 0.0023
667 LIP SWELLING 75 0.0022
668 NAUSEA 1782 0.0022
669 BACTERIAL INFECTION 42 0.0022
670 HEART RATE INCREASED 223 0.0022
671 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108 0.0022
672 EYE HAEMORRHAGE 30 0.0022
673 INTENTIONAL DOSE OMISSION 64 0.0022
674 THROMBOSIS 180 0.0022
675 OCULAR DISCOMFORT 25 0.0022
676 DECREASED ACTIVITY 24 0.0022
677 TASTE DISORDER 45 0.0022
678 WOUND 62 0.0022
679 EYE PAIN 125 0.0022
680 RESTLESSNESS 81 0.0022
681 UPPER RESPIRATORY TRACT INFECTION 102 0.0022
682 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157 0.0022
683 THROAT IRRITATION 99 0.0022
684 PERICARDIAL EFFUSION 51 0.0022
685 FLATULENCE 125 0.0022
686 ALOPECIA 432 0.0022
687 GENERAL PHYSICAL HEALTH DETERIORATION 254 0.0022
688 STOMATITIS 133 0.0022
689 CHILLS 257 0.0022
690 SCAB 25 0.0022
691 PRODUCT DOSE OMISSION IN ERROR 62 0.0022
692 INTERNAL HAEMORRHAGE 25 0.0022
693 DRUG PRESCRIBING ERROR 42 0.0022
694 MELAENA 48 0.0022
695 FIBROMYALGIA 53 0.0022
696 PRODUCT ADMINISTRATION ERROR 44 0.0022
697 OFF LABEL USE 1902 0.0022
698 ERUCTATION 42 0.0022
699 HAIR COLOUR CHANGES 27 0.0022
700 DYSPNOEA 1225 0.0022
701 COVID-19 379 0.0022
702 SPINAL FRACTURE 43 0.0021
703 PSORIATIC ARTHROPATHY 87 0.0021
704 ULCER 34 0.0021
705 FEELING HOT 131 0.0021
706 ABDOMINAL DISTENSION 223 0.0021
707 INTENTIONAL OVERDOSE 137 0.0021
708 SEROTONIN SYNDROME 41 0.0021
709 ILL-DEFINED DISORDER 129 0.0021
710 ACTIVITIES OF DAILY LIVING IMPAIRED 42 0.0021
711 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0021
712 BLOOD CREATININE INCREASED 138 0.0021
713 RETCHING 45 0.0021
714 HOSPITALISATION 324 0.0021
715 FEELING JITTERY 40 0.0021
716 OROPHARYNGEAL PAIN 194 0.0021
717 CEREBRAL HAEMORRHAGE 75 0.0021
718 ABNORMAL BEHAVIOUR 83 0.0021
719 RENAL IMPAIRMENT 176 0.0021
720 NECK PAIN 117 0.0021
721 DIVERTICULITIS 58 0.0021
722 ACUTE RESPIRATORY DISTRESS SYNDROME 37 0.0021
723 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
724 CHEST DISCOMFORT 214 0.0021
725 JAUNDICE 56 0.0021
726 MALAISE 912 0.0021
727 DEVICE RELATED INFECTION 32 0.0021
728 NERVOUSNESS 108 0.0021
729 DYSTONIA 40 0.0021
730 FEELING ABNORMAL 494 0.0021
731 CARDIAC FAILURE 165 0.0021
732 GLOSSODYNIA 46 0.0021
733 ORAL HERPES 40 0.0020
734 SPLENOMEGALY 24 0.0020
735 CEREBROVASCULAR ACCIDENT 347 0.0020
736 CONJUNCTIVITIS 38 0.0020
737 TOOTH INFECTION 27 0.0020
738 NEUTROPENIA 278 0.0020
739 SKIN LESION 56 0.0020
740 DISTURBANCE IN ATTENTION 110 0.0020
741 ABDOMINAL PAIN UPPER 419 0.0020
742 HEAD DISCOMFORT 36 0.0020
743 INSURANCE ISSUE 31 0.0020
744 HEADACHE 1270 0.0020
745 INFLUENZA 225 0.0020
746 RENAL DISORDER 94 0.0020
747 CANDIDA INFECTION 34 0.0020
748 FEELING COLD 56 0.0020
749 GOUT 36 0.0020
750 TENDONITIS 31 0.0020
751 SKIN CANCER 43 0.0020
752 BLOOD CHOLESTEROL INCREASED 93 0.0020
753 MUSCULOSKELETAL PAIN 104 0.0020
754 GLYCOSYLATED HAEMOGLOBIN INCREASED 50 0.0020
755 ABDOMINAL DISCOMFORT 330 0.0020
756 RHINORRHOEA 127 0.0020
757 RASH PAPULAR 44 0.0020
758 GALLBLADDER DISORDER 35 0.0020
759 INFLAMMATION 101 0.0020
760 COUGH 547 0.0019
761 PHARYNGEAL OEDEMA 30 0.0019
762 DEPRESSED MOOD 103 0.0019
763 IMMUNODEFICIENCY 29 0.0019
764 NEUROTOXICITY 34 0.0019
765 GENERALISED OEDEMA 24 0.0019
766 FULL BLOOD COUNT DECREASED 39 0.0019
767 LOWER RESPIRATORY TRACT INFECTION 88 0.0019
768 INTENTIONAL PRODUCT MISUSE 169 0.0019
769 FLUID OVERLOAD 28 0.0019
770 NERVOUS SYSTEM DISORDER 60 0.0019
771 HYPERGLYCAEMIA 70 0.0019
772 ABNORMAL DREAMS 53 0.0019
773 TREATMENT NONCOMPLIANCE 105 0.0019
774 SECRETION DISCHARGE 24 0.0019
775 PANCYTOPENIA 107 0.0019
776 DIABETES MELLITUS 145 0.0019
777 BLOOD GLUCOSE ABNORMAL 35 0.0019
778 GASTRIC ULCER 36 0.0019
779 HYPERSENSITIVITY 351 0.0019
780 ALANINE AMINOTRANSFERASE INCREASED 116 0.0019
781 SKIN DISORDER 63 0.0019
782 SINUSITIS 193 0.0019
783 SWELLING 176 0.0019
784 COLON CANCER 28 0.0019
785 METASTASES TO LIVER 33 0.0019
786 GASTRIC DISORDER 64 0.0019
787 INJECTION SITE EXTRAVASATION 23 0.0019
788 HERNIA 36 0.0019
789 JOINT SWELLING 224 0.0019
790 LACTIC ACIDOSIS 60 0.0019
791 THROAT TIGHTNESS 50 0.0018
792 ASPARTATE AMINOTRANSFERASE INCREASED 98 0.0018
793 WEIGHT INCREASED 412 0.0018
794 SEASONAL ALLERGY 26 0.0018
795 THROMBOCYTOPENIA 205 0.0018
796 VIRAL INFECTION 61 0.0018
797 GASTROENTERITIS VIRAL 33 0.0018
798 IMPAIRED HEALING 60 0.0018
799 MANIA 30 0.0018
800 DISABILITY 36 0.0018
801 ABDOMINAL PAIN LOWER 46 0.0018
802 LUNG DISORDER 89 0.0018
803 HYPOACUSIS 78 0.0018
804 PANIC ATTACK 66 0.0018
805 INFLUENZA LIKE ILLNESS 149 0.0018
806 DRUG DOSE OMISSION 299 0.0018
807 CARDIAC DISORDER 169 0.0018
808 HAEMORRHAGE INTRACRANIAL 27 0.0018
809 RESPIRATORY TRACT INFECTION 47 0.0018
810 PNEUMONITIS 49 0.0018
811 FAECES DISCOLOURED 39 0.0018
812 ISCHAEMIC STROKE 32 0.0018
813 QUALITY OF LIFE DECREASED 24 0.0018
814 ARTHRALGIA 743 0.0018
815 NASAL CONGESTION 105 0.0018
816 TINNITUS 82 0.0018
817 DEVICE OCCLUSION 25 0.0018
818 TARDIVE DYSKINESIA 50 0.0018
819 EPILEPSY 54 0.0018
820 MIGRAINE 168 0.0018
821 PRESCRIBED OVERDOSE 34 0.0018
822 JOINT STIFFNESS 46 0.0018
823 DEATH 1506 0.0017
824 BONE PAIN 102 0.0017
825 LUNG INFECTION 27 0.0017
826 TOOTH LOSS 36 0.0017
827 NIGHTMARE 60 0.0017
828 C-REACTIVE PROTEIN INCREASED 63 0.0017
829 AGEUSIA 43 0.0017
830 PLATELET COUNT DECREASED 183 0.0017
831 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
832 FEMUR FRACTURE 53 0.0017
833 BLOOD TEST ABNORMAL 24 0.0017
834 RASH GENERALISED 44 0.0017
835 DYSGEUSIA 126 0.0017
836 PALLOR 46 0.0017
837 SKIN HAEMORRHAGE 25 0.0017
838 PALPITATIONS 197 0.0017
839 LIVER FUNCTION TEST INCREASED 36 0.0017
840 INCREASED APPETITE 32 0.0017
841 ASTHMA 188 0.0017
842 LEUKOPENIA 83 0.0017
843 HYPERTHYROIDISM 24 0.0017
844 ORAL DISCOMFORT 23 0.0017
845 EAR INFECTION 44 0.0017
846 SWELLING FACE 107 0.0016
847 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
848 WHEEZING 97 0.0016
849 ASCITES 48 0.0016
850 OVERDOSE 351 0.0016
851 ADVERSE DRUG REACTION 146 0.0016
852 CRYING 59 0.0016
853 HEPATOCELLULAR INJURY 23 0.0016
854 DRUG WITHDRAWAL SYNDROME NEONATAL 24 0.0016
855 DIALYSIS 23 0.0016
856 TREATMENT FAILURE 134 0.0016
857 LIVER INJURY 39 0.0016
858 MYALGIA 270 0.0016
859 METASTASES TO BONE 26 0.0016
860 NIGHT SWEATS 51 0.0016
861 AGGRESSION 79 0.0016
862 PREMATURE DELIVERY 25 0.0016
863 CHOLESTASIS 30 0.0016
864 URTICARIA 259 0.0015
865 PELVIC PAIN 28 0.0015
866 DEAFNESS 40 0.0015
867 WITHDRAWAL SYNDROME 64 0.0015
868 GASTROINTESTINAL DISORDER 136 0.0015
869 ANGIOEDEMA 67 0.0015
870 NASOPHARYNGITIS 279 0.0015
871 NEEDLE ISSUE 44 0.0015
872 INTENTIONAL PRODUCT USE ISSUE 132 0.0015
873 PRODUCT DOSE OMISSION ISSUE 442 0.0015
874 THINKING ABNORMAL 28 0.0015
875 HEPATIC ENZYME INCREASED 102 0.0015
876 TYPE 2 DIABETES MELLITUS 50 0.0015
877 SKIN FISSURES 29 0.0015
878 DRY SKIN 198 0.0015
879 MULTIPLE ORGAN DYSFUNCTION SYNDROME 42 0.0015
880 EMOTIONAL DISTRESS 179 0.0015
881 ANGER 50 0.0015
882 COLD SWEAT 26 0.0015
883 LYMPHADENOPATHY 52 0.0015
884 RHEUMATOID ARTHRITIS 166 0.0015
885 MULTIPLE FRACTURES 24 0.0015
886 DRUG INTOLERANCE 141 0.0015
887 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25 0.0015
888 MYOCARDIAL INFARCTION 254 0.0015
889 OCULAR HYPERAEMIA 69 0.0015
890 SKIN EXFOLIATION 121 0.0014
891 MOOD ALTERED 39 0.0014
892 HEPATIC FAILURE 43 0.0014
893 PRODUCT USE IN UNAPPROVED INDICATION 353 0.0014
894 NEUTROPHIL COUNT DECREASED 58 0.0014
895 SUICIDE ATTEMPT 86 0.0014
896 BLOOD GLUCOSE DECREASED 68 0.0014
897 BLOOD BILIRUBIN INCREASED 38 0.0014
898 THERAPEUTIC PRODUCT EFFECT DECREASED 63 0.0014
899 PANCREATITIS 74 0.0014
900 ADVERSE EVENT 129 0.0014
901 INTENTIONAL SELF-INJURY 28 0.0014
902 PANCREATITIS ACUTE 31 0.0014
903 PRODUCT DISPENSING ERROR 30 0.0014
904 HAEMORRHAGE 144 0.0014
905 PRODUCT SUBSTITUTION ISSUE 79 0.0014
906 PRODUCT AVAILABILITY ISSUE 31 0.0014
907 UNDERDOSE 99 0.0014
908 DRUG ABUSE 112 0.0013
909 EYE SWELLING 50 0.0013
910 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 272 0.0013
911 CARDIOVASCULAR DISORDER 34 0.0013
912 INTENTIONAL DRUG MISUSE 28 0.0013
913 EYE IRRITATION 77 0.0013
914 IRRITABILITY 79 0.0013
915 MEDICATION ERROR 73 0.0013
916 ILLNESS 134 0.0013
917 THERAPEUTIC RESPONSE SHORTENED 43 0.0013
918 PREMATURE BABY 39 0.0013
919 VAGINAL HAEMORRHAGE 56 0.0013
920 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 30 0.0013
921 SKIN BURNING SENSATION 92 0.0013
922 SUICIDAL IDEATION 117 0.0013
923 PRODUCT PRESCRIBING ERROR 30 0.0013
924 RASH MACULO-PAPULAR 28 0.0013
925 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 225 0.0012
926 BLOOD GLUCOSE INCREASED 235 0.0012
927 INJECTION SITE MASS 46 0.0012
928 DERMATITIS 26 0.0012
929 PSORIASIS 162 0.0012
930 BONE MARROW FAILURE 25 0.0012
931 LUNG NEOPLASM MALIGNANT 50 0.0012
932 DRUG RESISTANCE 31 0.0012
933 PLASMA CELL MYELOMA 47 0.0012
934 THERAPEUTIC RESPONSE DECREASED 73 0.0012
935 SNEEZING 27 0.0012
936 MATERNAL EXPOSURE DURING PREGNANCY 107 0.0012
937 DISEASE RECURRENCE 57 0.0012
938 MALIGNANT NEOPLASM PROGRESSION 122 0.0012
939 EYE PRURITUS 40 0.0012
940 PAIN OF SKIN 32 0.0012
941 NEOPLASM MALIGNANT 79 0.0012
942 INCORRECT DOSE ADMINISTERED 265 0.0012
943 PERITONITIS 24 0.0012
944 ERECTILE DYSFUNCTION 29 0.0011
945 BONE DENSITY DECREASED 35 0.0011
946 INJECTION SITE REACTION 76 0.0011
947 MOOD SWINGS 35 0.0011
948 DEVICE ISSUE 98 0.0011
949 OSTEONECROSIS OF JAW 27 0.0011
950 STEVENS-JOHNSON SYNDROME 24 0.0011
951 IMPAIRED WORK ABILITY 23 0.0011
952 INCORRECT PRODUCT ADMINISTRATION DURATION 23 0.0011
953 FOETAL EXPOSURE DURING PREGNANCY 86 0.0011
954 CONTRAINDICATED PRODUCT ADMINISTERED 32 0.0011
955 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 35 0.0010
956 HEPATOTOXICITY 23 0.0010
957 PHARMACEUTICAL PRODUCT COMPLAINT 26 0.0010
958 LACRIMATION INCREASED 30 0.0010
959 HEPATITIS 25 0.0010
960 DEVICE MALFUNCTION 68 0.0010
961 HEPATIC FUNCTION ABNORMAL 36 0.0010
962 DIABETIC KETOACIDOSIS 23 0.0010
963 INJECTION SITE PRURITUS 64 0.0010
964 LIVER DISORDER 42 0.0009
965 DEVICE DISLOCATION 41 0.0009
966 INJECTION SITE URTICARIA 23 0.0009
967 EXPOSURE DURING PREGNANCY 57 0.0009
968 EXTRA DOSE ADMINISTERED 36 0.0009
969 ECZEMA 46 0.0009
970 INJECTION SITE ERYTHEMA 105 0.0008
971 ACNE 63 0.0008
972 OSTEONECROSIS 27 0.0008
973 INJECTION SITE HAEMORRHAGE 65 0.0008
974 NEOPLASM PROGRESSION 28 0.0008
975 INJECTION SITE BRUISING 64 0.0008
976 INJECTION SITE PAIN 241 0.0008
977 INJECTION SITE RASH 24 0.0008
978 INJECTION SITE SWELLING 59 0.0008
979 DEVICE BREAKAGE 31 0.0008
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 33 0.0007
981 INCORRECT ROUTE OF DRUG ADMINISTRATION 25 0.0007
982 SYSTEMIC LUPUS ERYTHEMATOSUS 24 0.0007
983 DRUG WITHDRAWAL SYNDROME 55 0.0006
984 BREAST CANCER 57 0.0006
985 DEVICE LEAKAGE 26 0.0006
986 INTERSTITIAL LUNG DISEASE 28 0.0006
987 PRODUCT STORAGE ERROR 48 0.0005
988 NO ADVERSE EVENT 97 0.0005
989 PROSTATE CANCER 43 0.0005
990 DERMATITIS ATOPIC 26 0.0005
991 DRUG DEPENDENCE 56 0.0003
992 ACCIDENTAL EXPOSURE TO PRODUCT 33 0.0003
993 DRUG DOSE OMISSION BY DEVICE 23 0.0003